Top

Published in:

01-08-2012 | Original Article

Abnormal sleep patterns in subjects with type II diabetes mellitus and its effect on diabetic microangiopathies: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 20)

Authors: Rajiv Raman, Aditi Gupta, Kadri Venkatesh, Vaitheeswaran Kulothungan, Tarun Sharma

Published in: Acta Diabetologica | Issue 4/2012

Abstract

To study the prevalence of Abnormal Sleep Patterns (ASPs), gender-wise, in subjects with type II diabetes mellitus and its influence on diabetic microangiopathies. A population-based cross-sectional survey was conducted among 1,414 patients having type II diabetes mellitus. Diabetic retinopathy was graded using stereoscopic digital fundus photography. Neuropathy was assessed by measuring vibration perception threshold using a sensitometer. Nephropathy was diagnosed by the presence of microalbuminuria in the first morning urine sample. ASPs were defined as either short (less than 5 h) or long (more than 9 h) duration of sleep with excessive daytime sleepiness. The Epworth Sleepiness Scale (ESS) score was assessed to note excessive daytime sleepiness; a score of more than 10 was considered as abnormal. The prevalence of ASPs was more in subjects with diabetes than with those without diabetes (14.8 vs. 6.6%) (P = 0.009), especially in women (15.7 vs. 5.6%) (P = 0.021). Likewise, the prevalence of short duration of sleep was higher in subjects with diabetes compared to those without diabetes (6.6 vs. 2.2%) (P = 0.040). The mean age of women subjects with diabetes, having ASPs, was higher than those without diabetes (56.4 ± 8.9 years vs. 47.2 ± 5.9 years, P = 0.033). Women subjects with ASPs had a higher risk of diabetic neuropathy on both univariate and multivariate analysis. ASPs are not only related to diabetes but can also influence the microvascular complications arising due to diabetes, particularly diabetic neuropathy. Diabetology and sleep medicine specialists need to work together to prevent the negative interactions between these two groups.

Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Walter R, Ewy GA, Howard BV, Punjabi NM, Sleep Heart Health Study (2003) Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 26(3):702–709PubMedCrossRef

Sridhar GR, Madhu K (1994) Prevalence of sleep disturbances in diabetes mellitus. Diabetes Res Clin Pract 23(3):183–186PubMedCrossRef

Kawakami N, Takatsuka N, Shimizu H (2004) Sleep disturbance and onset of type 2 diabetes. Diabetes Care 27(1):282–283PubMedCrossRef

Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, Baldwin CM, Nieto FJ (2005) Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 165(8):863–867PubMedCrossRef

Tuomilehto H, Peltonen M, Partinen M, Seppä J, Saaristo T, Korpi-Hyövälti E, Oksa H, Puolijoki H, Saltevo J, Vanhala M, Tuomilehto J (2008) Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women—The FIN-D2D survey. Sleep Med 9(3):221–227PubMedCrossRef

Chaput JP, Després JP, Bouchard C, Tremblay A (2007) Association of sleep duration with type 2 diabetes and impaired glucose tolerance. Diabetologia 50(11):2298–2304PubMedCrossRef

Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, Patel S, Hu FB (2003) A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26(2):380–384PubMedCrossRef

Mallon L, Broman JE, Hetta J (2005) High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care 28(11):2762–2767PubMedCrossRef

Yaggi HK, Araujo AB, McKinlay JB (2006) Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 29(3):657–661PubMedCrossRef

10.

Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, Rundle AG, Zammit GK, Malaspina D (2007) Sleep duration as a risk factor for diabetes incidence in a large US sample. Sleep 30(12):1667–1673PubMed

11.

Zizi F, Jean-Louis G, Brown CD, Ogedegbe G, Boutin-Foster C, McFarlane SI (2010) Sleep duration and the risk of diabetes mellitus: epidemiologic evidence and pathophysiologic insights. Curr Diab Rep 10(1):43–47PubMedCrossRef

12.

Tuomilehto H, Peltonen M, Partinen M, Lavigne G, Eriksson JG, Herder C, Aunola S, Keinänen-Kiukaanniemi S, Ilanne-Parikka P, Uusitupa M, Tuomilehto J, Lindström J, Finnish Diabetes Prevention Study Group (2009) Sleep duration, lifestyle intervention, and incidence of type 2 diabetes in impaired glucose tolerance: The Finnish Diabetes Prevention Study. Diabetes Care 32(11):1965–1971PubMedCrossRef

13.

Jennum P, Schultz-Larsen K, Christensen N (1993) Snoring, sympathetic activity and cardiovascular risk factors in a 70 year old population. Eur J Epidemiol 9(5):477–482PubMedCrossRef

14.

Grunstein R, Wilcox I, Yang TS, Gould Y, Hedner J (1993) Snoring and sleep apnea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord 17(9):533–540PubMed

15.

Al-Delaimy W, Manson JE, Willett WC, Stampfer MJ, Hu FB (2002) Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 155(5):387–393PubMedCrossRef

16.

Elmasry A, Janson C, Lindberg E, Gislason T, Tageldin MA, Boman G (2000) The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med 248(1):13–20PubMedCrossRef

17.

Renko AK, Hiltunen L, Laakso M, Rajala U, Keinänen-Kiukaanniemi S (2005) The relationship of glucose tolerance to sleep disorders and daytime sleepiness. Diabetes Res Clin Pract 67(1):84–91PubMedCrossRef

18.

Gislason T, Taube A (1987) Prevalence of sleep apnea syndrome–estimation by two stage sampling. Ups J Med Sci 92(2):193–203PubMedCrossRef

19.

Lindberg E, Berne C, Franklin KA, Svensson M, Janson C (2007) Snoring and daytime sleepiness as risk factors for hypertension and diabetes in women–a population-based study. Respir Med 101(6):1283–1290PubMedCrossRef

20.

Chasens ER, Sereika SM, Burke LE (2009) Daytime sleepiness and functional outcomes in older adults with diabetes. Diabetes Educ 35(3):455–464PubMedCrossRef

21.

Vgontzas AN, Chrousos GP (2002) Sleep-disordered breathing, sleepiness, and insulin resistance: is the latter a consequence, a pathogenetic factor, or both? Sleep Med 3(5):389–391PubMedCrossRef

22.

Knutson KL, Ryden AM, Mander BA, Van Cauter E (2006) Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 166(16):1768–1774PubMedCrossRef

23.

Sauvet F, Leftheriotis G, Gomez-Merino D, Langrume C, Drogou C, Van Beers P, Bourrilhon C, Florence G, Chennaoui M (2010) Effect of acute sleep deprivation on vascular function in healthy subjects. J Appl Physiol 108(1):68–75PubMedCrossRef

24.

Björkelund C, Bengtsson C, Lissner L, Rödström K (2002) Women’s sleep: longitudinal changes and secular trends in a 24-year perspective. Results of the population study of women in Gothenburg, Sweden. Sleep 25(8):894–896PubMed

25.

Hayashino Y, Fukuhara S, Suzukamo Y, Okamura T, Tanaka T, Ueshima H, HIPOP-OHP Research group (2007) Relation between sleep quality and quantity, quality of life, and risk of developing diabetes in healthy workers in Japan: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) Study. BMC Public Health 7:129PubMedCrossRef

26.

Hyyppä MT, Kronholm E (1989) Quality of sleep and chronic illnesses. J Clin Epidemiol 42(7):633–638PubMedCrossRef

27.

Chin K, Oga T, Takahashi K, Takegami M, Nakayama-Ashida Y, Wakamura T, Sumi K, Nakamura T, Horita S, Oka Y, Minami I, Fukuhara S, Kadotani H (2010) Associations between obstructive sleep apnea, metabolic syndrome, and sleep duration, as measured with an actigraph, in an urban male working population in Japan. Sleep 33(1):89–95PubMed

28.

Schuster SR, Tabba M, Sahota P (2006) Relationship between the cardiometabolic syndrome and obstructive sleep apnea. J Cardiometab Syndr 1(3):204–208PubMedCrossRef

29.

Chorostowska-Wynimko J, Radomska D, Pływaczewski R, Jończak L, Stepniewska A, Górecka D, Skopińska-Rózewska E (2005) Disturbed angiogenic activity in sera from obstructive sleep apnea patients. J Physiol Pharmacol 56(Suppl 4):71–77PubMed

30.

Agarwal S, Raman R, Paul PG, Rani PK, Uthra S, Gayathree R, McCarty C, Kumaramanickavel G, Sharma T (2005) Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): study design and research methodology. Ophthalmic Epidemiol 12(2):143–153PubMedCrossRef

31.

Touitou Y, Portaluppi F, Smolensky MH, Rensing L (2004) Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol Int 21(1):161–170PubMedCrossRef

32.

American Diabetes Association (2003) Tests of glycemia in diabetes. Diabetes Care 26(Suppl 1):s106–s108

33.

Klein R, Klein BE, Magli YL, Brothers RJ, Meuer SM, Moss SE, Davis MD (1986) An alternative method of grading diabetic retinopathy. Ophthalmology 93(9):1183–1187PubMed

34.

Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, Steffes MW, American Diabetes Association (2004) Nephropathy in diabetes. Diabetes Care 27(Suppl 1):S79–S83PubMed

35.

Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V (2008) Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES-55). Diabet Med 25(4):407–412PubMedCrossRef

36.

Nevsimalova S (2002) Excessive daytime sleepiness. In: Reisin RC, Nuwer MR, Hallett M, Medina C (eds) Advances in clinical neurophysiology: supplements to clinical neurophysiology, 1st edn. Elsevier, The Netherlands, pp 175–179

37.

Johns MW (1993) Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth sleepiness Scale. Chest 103(1):30–36PubMedCrossRef

38.

Spiegel K, Tasali E, Penev P, Van Cauter E (2004) Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141(11):846–850PubMed

39.

Meisinger C, Heier M, Loewel H, MONICA/KORA Augsburg Cohort study (2005) Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 48(2):235–241PubMedCrossRef

40.

Spiegel K, Leproult R, Van Cauter E (1999) Impact of sleep debt on metabolic and endocrine function. Lancet 354(9188):1435–1439PubMedCrossRef

41.

Wolk R, Svatikova A, Nelson CA, Gami AS, Govender K, Winnicki M, Somers VK (2005) Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res 13(1):186–190PubMedCrossRef

42.

Raman R, Rani PK, Gnanamoorthy P, Sudhir RR, Kumaramanikavel G, Sharma T (2010) Association of obesity with diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS Report no. 8). Acta Diabetol 47(3):209–215PubMedCrossRef

Title: Abnormal sleep patterns in subjects with type II diabetes mellitus and its effect on diabetic microangiopathies: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 20)
Authors: Rajiv Raman
Aditi Gupta
Kadri Venkatesh
Vaitheeswaran Kulothungan
Tarun Sharma
Publication date: 01-08-2012
Publisher: Springer Milan
Published in: Acta Diabetologica / Issue 4/2012
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-010-0240-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abnormal sleep patterns in subjects with type II diabetes mellitus and its effect on diabetic microangiopathies: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 20)

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2012

Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes

Molecular mechanisms of muscarinic acetylcholine receptor–stimulated increase in cytosolic free Ca2+ concentration and ERK1/2 activation in the MIN6 pancreatic β-cell line

Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients

Structural damage in diabetic nephropathy is associated with TNF-α system activity

Post-prandial glucose and diabetic complications: systematic review of observational studies

Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page